| 1 |
Setty BA， O'Brien SH， Kerlin BA.Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases ［J］.Pediatr Blood Cancer， 2012， 59 (2): 258-264.
|
| 2 |
Raffini L， Huang YS， Witmer C， et al.Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007［J］.Pediatrics， 2009， 124 (4): 1001-1008.
|
| 3 |
Manlhiot C， Menjak IB， Brandao LR， et al.Risk， clinical features， and outcomes of thrombosis associated with pediatric cardiac surgery ［J］.Circulation， 2011，124 (14): 1511-1519.
|
| 4 |
Manlhiot C， Brandao LR， Schwartz SM， et al.Management and outcomes of patients with occlusive thrombosis after pediatric cardiac surgery［J］.J Pediatr，2016 (169): 146-153.
|
| 5 |
Ansah DA， Patel KN， Montegna L， et al.Tissue plasminogenactivatoruseinchildren:bleeding complications and thrombus resolution ［J］.J Pediatr，2016 (171): 67-72.e1-2.
|
| 6 |
宫明，李晓英，徐彬，等.超声对临床症状隐匿的小儿中心静脉导管相关性血栓的评估价值探讨［J/CD］.中华危重症医学杂志（电子版），2018，11（5）：344-346.
|
| 7 |
季必宏，邹伟荣，许海林，等.导管溶栓治疗急性下肢深静脉血栓形成患者的临床应用［J/CD］.中华危重症医学杂志（电子版），2016，9（1）：41-43.
|
| 8 |
Monagle P， Chan AKC， Goldenberg NA， et al.Antithrombotic therapy in neonates and children:antithrombotic therapy and prevention of thrombosis，9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ［J］.Chest，2012， 141 (2 Suppl): e737S-e801S.
|
| 9 |
Raffini L.Thrombolysis for intravascular thrombosis in neonates and children［J］.Curr Opin Pediatr， 2009， 21(1): 9-14.
|
| 10 |
Leong R， Patel J， Samji N， et al.Use of thrombolytic agents to treat neonatal thrombosis in clinical practice［J］.Blood Coagul Fibrinolysis， 2022， 33 (4): 193-200.
|
| 11 |
Burrows PE， Benson LN， Williams WG， et al.Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children ［J］.Circulation， 1990， 82 (5): 1697-1704.
|
| 12 |
El-Segaier M， Khan MA， Khan ZU， et al.Recombinant tissue plasminogen activator in the treatment of neonates with intracardiac and great vessels thrombosis［J］.Pediatr Cardiol， 2015， 36 (8): 1582-1587.
|
| 13 |
De Castro S， Magni G， Beni S， et al.Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves［J］.Am J Cardio， 1997， 80 (8): 1030-1034.
|
| 14 |
Parmar N， Albisetti M， Berry LR， et al.The fibrinolytic system in newborns and children ［J］.Clin Lab，2006， 52 (3-4): 115-124.
|
| 15 |
Parmar N， Mitchell LG， Berry LR， et al.The influence of age on in vitro plasmin generation in the presence of fibrin monomer ［J］.Acta Haematol， 2006，115 (3-4): 141-151.
|
| 16 |
Taha A， Rajgarhia A， Alsaleem M.Bivalirudin and thrombolytic therapy: a novel successful treatment of severe aortic arch thrombosis in a term neonate［J］.BMJ Case Rep， 2021， 14 (1): e239535.
|
| 17 |
Kara M， Güler M， Keskin Yildirim Z， et al.Clinical features and treatment results in preterm infants with intracardiac thrombus［J］.J Matern Fetal Neonatal Med，2021， 34 (11): 1763-1767.
|
| 18 |
Niada F， Tabin R， Kayemba-Kay's S.Spontaneous neonatal renal vein thromboses: should we treat them all？ A report of five cases and a literature review［J］.Pediatr Neonatol， 2018， 59 (3): 281-287.
|
| 19 |
Mahaffey KW， Granger CB， Collins R， et al.Overview of randomized trials of intravenous heparin in patients withacutemyocardialinfarctiontreatedwith thrombolytic therapy ［J］.Am J Cardiol， 1996， 77 (8):551-556.
|
| 20 |
Albisetti M.Thrombolytic therapy in children ［J］.Thromb Res， 2006， 118 (1): 95-105.
|
| 21 |
Gupta AA， Leaker M， Andrew M， et al.Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children［J］.J Pediatr， 2001， 139 (5): 682-688.
|
| 22 |
Manco-Johnson MJ， Nuss R， Hays T， et al.Combined thrombolytic and anticoagulant therapy for venous thrombosis in children ［J］.J Pediatr， 2000， 136 (4):446-453.
|
| 23 |
Saxena A， Gupta R， Kumar RK， et al.Predictors of arterialthrombosisafterdiagnosticcardiac catheterization in infants and children randomized to two heparin dosages［J］.Cathet Cardiovasc Diagn， 1997，41 (4): 400-403.
|